136 related articles for article (PubMed ID: 16822878)
21. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters.
Oliveira CR; Mendonça BB; Camargo OP; Pinto EM; Nascimento SA; Latorre Mdo R; Zerbini MC
Clinics (Sao Paulo); 2007 Apr; 62(2):167-74. PubMed ID: 17505702
[TBL] [Abstract][Full Text] [Related]
22. Osteoblastic osteosarcoma: cytomorphologic characteristics and differential diagnosis on fine-needle aspiration.
Sathiyamoorthy S; Ali SZ
Acta Cytol; 2012; 56(5):481-6. PubMed ID: 23075887
[TBL] [Abstract][Full Text] [Related]
23. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
24. Osteoblastoma-like osteosarcoma.
Tani T; Okada K; Shoji K; Hashimoto M; Sageshima M
Skeletal Radiol; 2000 Nov; 29(11):656-9. PubMed ID: 11201036
[TBL] [Abstract][Full Text] [Related]
25. Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience.
Bertoni F; Bacchini P; Donati D; Martini A; Picci P; Campanacci M
Mod Pathol; 1993 Nov; 6(6):707-16. PubMed ID: 8302813
[TBL] [Abstract][Full Text] [Related]
26. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.
Kloen P; Gebhardt MC; Perez-Atayde A; Rosenberg AE; Springfield DS; Gold LI; Mankin HJ
Cancer; 1997 Dec; 80(12):2230-9. PubMed ID: 9404699
[TBL] [Abstract][Full Text] [Related]
27. Osteoblastoma of the foot and ankle.
Temple HT; Mizel MS; Murphey MD; Sweet DE
Foot Ankle Int; 1998 Oct; 19(10):698-704. PubMed ID: 9801085
[TBL] [Abstract][Full Text] [Related]
28. Her-2/neu, p-53, and their coexpression in osteosarcoma.
Bakhshi S; Gupta A; Sharma MC; Khan SA; Rastogi S
J Pediatr Hematol Oncol; 2009 Apr; 31(4):245-51. PubMed ID: 19346874
[TBL] [Abstract][Full Text] [Related]
29. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic criteria for pseudomalignant osteoblastoma.
Cheung FM; Wu WC; Lam CK; Fu YK
Histopathology; 1997 Aug; 31(2):196-200. PubMed ID: 9279574
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
[TBL] [Abstract][Full Text] [Related]
32. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
[TBL] [Abstract][Full Text] [Related]
33. Osteoblastoma-like osteosarcoma: high-grade or low-grade osteosarcoma?
Gambarotti M; Dei Tos AP; Vanel D; Picci P; Gibertoni D; Klein MJ; Righi A
Histopathology; 2019 Feb; 74(3):494-503. PubMed ID: 30152881
[TBL] [Abstract][Full Text] [Related]
34. Osteoblastoma of the jaw: report of two cases and review of the literature.
Angiero F; Mellone P; Baldi A; Stefani M
In Vivo; 2006; 20(5):665-70. PubMed ID: 17091775
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcoma.
Riester SM; Torres-Mora J; Dudakovic A; Camilleri ET; Wang W; Xu F; Thaler RR; Evans JM; Zwartbol R; Briaire-de Bruijn IH; Maran A; Folpe AL; Inwards CY; Rose PS; Shives TC; Yaszemski MJ; Sim FH; Deyle DR; Larson AN; Galindo MA; Cleven AGH; Oliveira AM; Cleton-Jansen AM; Bovée JVMG; van Wijnen AJ
J Orthop Res; 2017 May; 35(5):1137-1146. PubMed ID: 27324965
[TBL] [Abstract][Full Text] [Related]
37. CD138 (syndecan-1) expression in bone-forming tumors.
Nunez AL; Siegal GP; Reddy VV; Wei S
Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
[TBL] [Abstract][Full Text] [Related]
38. Osteoblastoma of the nasal septum.
Young E; Dabrowski M; Brelsford K
J Laryngol Otol; 2011 Oct; 125(10):1062-6. PubMed ID: 21806856
[TBL] [Abstract][Full Text] [Related]
39. Osteoblastoma like osteosarcoma.
Hermann G; Klein MJ; Springfield D; Abdelwahab IF
Clin Radiol; 2004 Jan; 59(1):105-8. PubMed ID: 14697384
[No Abstract] [Full Text] [Related]
40. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
